POC Infectious Diseases market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global POC Infectious Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Flu Adenovirus Malaria Streptococcal Bacteremia Tuberculosis (TB) Occult Blood HIV Segment by Application Hospital& Clinics Clinical Diagnostic Laboratories Homecare Settings By Company Abbott Meridian Bioscience Orasure Technologies Trinity Biotech Beckman Coulter/ Danaher Becton Dickinson Biomerieux Bio-Rad Cepheid Diamedix Diasorin Eiken Chemical Enzo Biochem By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global POC Infectious Diseases Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Flu 1.2.3 Adenovirus 1.2.4 Malaria 1.2.5 Streptococcal Bacteremia 1.2.6 Tuberculosis (TB) 1.2.7 Occult Blood 1.2.8 HIV 1.3 Market by Application 1.3.1 Global POC Infectious Diseases Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital& Clinics 1.3.3 Clinical Diagnostic Laboratories 1.3.4 Homecare Settings 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global POC Infectious Diseases Market Perspective (2017-2028) 2.2 POC Infectious Diseases Growth Trends by Region 2.2.1 POC Infectious Diseases Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 POC Infectious Diseases Historic Market Size by Region (2017-2022) 2.2.3 POC Infectious Diseases Forecasted Market Size by Region (2023-2028) 2.3 POC Infectious Diseases Market Dynamics 2.3.1 POC Infectious Diseases Industry Trends 2.3.2 POC Infectious Diseases Market Drivers 2.3.3 POC Infectious Diseases Market Challenges 2.3.4 POC Infectious Diseases Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top POC Infectious Diseases Players by Revenue 3.1.1 Global Top POC Infectious Diseases Players by Revenue (2017-2022) 3.1.2 Global POC Infectious Diseases Revenue Market Share by Players (2017-2022) 3.2 Global POC Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by POC Infectious Diseases Revenue 3.4 Global POC Infectious Diseases Market Concentration Ratio 3.4.1 Global POC Infectious Diseases Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by POC Infectious Diseases Revenue in 2021 3.5 POC Infectious Diseases Key Players Head office and Area Served 3.6 Key Players POC Infectious Diseases Product Solution and Service 3.7 Date of Enter into POC Infectious Diseases Market 3.8 Mergers & Acquisitions, Expansion Plans 4 POC Infectious Diseases Breakdown Data by Type 4.1 Global POC Infectious Diseases Historic Market Size by Type (2017-2022) 4.2 Global POC Infectious Diseases Forecasted Market Size by Type (2023-2028) 5 POC Infectious Diseases Breakdown Data by Application 5.1 Global POC Infectious Diseases Historic Market Size by Application (2017-2022) 5.2 Global POC Infectious Diseases Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America POC Infectious Diseases Market Size (2017-2028) 6.2 North America POC Infectious Diseases Market Size by Type 6.2.1 North America POC Infectious Diseases Market Size by Type (2017-2022) 6.2.2 North America POC Infectious Diseases Market Size by Type (2023-2028) 6.2.3 North America POC Infectious Diseases Market Share by Type (2017-2028) 6.3 North America POC Infectious Diseases Market Size by Application 6.3.1 North America POC Infectious Diseases Market Size by Application (2017-2022) 6.3.2 North America POC Infectious Diseases Market Size by Application (2023-2028) 6.3.3 North America POC Infectious Diseases Market Share by Application (2017-2028) 6.4 North America POC Infectious Diseases Market Size by Country 6.4.1 North America POC Infectious Diseases Market Size by Country (2017-2022) 6.4.2 North America POC Infectious Diseases Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe POC Infectious Diseases Market Size (2017-2028) 7.2 Europe POC Infectious Diseases Market Size by Type 7.2.1 Europe POC Infectious Diseases Market Size by Type (2017-2022) 7.2.2 Europe POC Infectious Diseases Market Size by Type (2023-2028) 7.2.3 Europe POC Infectious Diseases Market Share by Type (2017-2028) 7.3 Europe POC Infectious Diseases Market Size by Application 7.3.1 Europe POC Infectious Diseases Market Size by Application (2017-2022) 7.3.2 Europe POC Infectious Diseases Market Size by Application (2023-2028) 7.3.3 Europe POC Infectious Diseases Market Share by Application (2017-2028) 7.4 Europe POC Infectious Diseases Market Size by Country 7.4.1 Europe POC Infectious Diseases Market Size by Country (2017-2022) 7.4.2 Europe POC Infectious Diseases Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific POC Infectious Diseases Market Size (2017-2028) 8.2 Asia-Pacific POC Infectious Diseases Market Size by Type 8.2.1 Asia-Pacific POC Infectious Diseases Market Size by Type (2017-2022) 8.2.2 Asia-Pacific POC Infectious Diseases Market Size by Type (2023-2028) 8.2.3 Asia-Pacific POC Infectious Diseases Market Share by Type (2017-2028) 8.3 Asia-Pacific POC Infectious Diseases Market Size by Application 8.3.1 Asia-Pacific POC Infectious Diseases Market Size by Application (2017-2022) 8.3.2 Asia-Pacific POC Infectious Diseases Market Size by Application (2023-2028) 8.3.3 Asia-Pacific POC Infectious Diseases Market Share by Application (2017-2028) 8.4 Asia-Pacific POC Infectious Diseases Market Size by Region 8.4.1 Asia-Pacific POC Infectious Diseases Market Size by Region (2017-2022) 8.4.2 Asia-Pacific POC Infectious Diseases Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America POC Infectious Diseases Market Size (2017-2028) 9.2 Latin America POC Infectious Diseases Market Size by Type 9.2.1 Latin America POC Infectious Diseases Market Size by Type (2017-2022) 9.2.2 Latin America POC Infectious Diseases Market Size by Type (2023-2028) 9.2.3 Latin America POC Infectious Diseases Market Share by Type (2017-2028) 9.3 Latin America POC Infectious Diseases Market Size by Application 9.3.1 Latin America POC Infectious Diseases Market Size by Application (2017-2022) 9.3.2 Latin America POC Infectious Diseases Market Size by Application (2023-2028) 9.3.3 Latin America POC Infectious Diseases Market Share by Application (2017-2028) 9.4 Latin America POC Infectious Diseases Market Size by Country 9.4.1 Latin America POC Infectious Diseases Market Size by Country (2017-2022) 9.4.2 Latin America POC Infectious Diseases Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa POC Infectious Diseases Market Size (2017-2028) 10.2 Middle East & Africa POC Infectious Diseases Market Size by Type 10.2.1 Middle East & Africa POC Infectious Diseases Market Size by Type (2017-2022) 10.2.2 Middle East & Africa POC Infectious Diseases Market Size by Type (2023-2028) 10.2.3 Middle East & Africa POC Infectious Diseases Market Share by Type (2017-2028) 10.3 Middle East & Africa POC Infectious Diseases Market Size by Application 10.3.1 Middle East & Africa POC Infectious Diseases Market Size by Application (2017-2022) 10.3.2 Middle East & Africa POC Infectious Diseases Market Size by Application (2023-2028) 10.3.3 Middle East & Africa POC Infectious Diseases Market Share by Application (2017-2028) 10.4 Middle East & Africa POC Infectious Diseases Market Size by Country 10.4.1 Middle East & Africa POC Infectious Diseases Market Size by Country (2017-2022) 10.4.2 Middle East & Africa POC Infectious Diseases Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbott 11.1.1 Abbott Company Details 11.1.2 Abbott Business Overview 11.1.3 Abbott POC Infectious Diseases Introduction 11.1.4 Abbott Revenue in POC Infectious Diseases Business (2017-2022) 11.1.5 Abbott Recent Developments 11.2 Meridian Bioscience 11.2.1 Meridian Bioscience Company Details 11.2.2 Meridian Bioscience Business Overview 11.2.3 Meridian Bioscience POC Infectious Diseases Introduction 11.2.4 Meridian Bioscience Revenue in POC Infectious Diseases Business (2017-2022) 11.2.5 Meridian Bioscience Recent Developments 11.3 Orasure Technologies 11.3.1 Orasure Technologies Company Details 11.3.2 Orasure Technologies Business Overview 11.3.3 Orasure Technologies POC Infectious Diseases Introduction 11.3.4 Orasure Technologies Revenue in POC Infectious Diseases Business (2017-2022) 11.3.5 Orasure Technologies Recent Developments 11.4 Trinity Biotech 11.4.1 Trinity Biotech Company Details 11.4.2 Trinity Biotech Business Overview 11.4.3 Trinity Biotech POC Infectious Diseases Introduction 11.4.4 Trinity Biotech Revenue in POC Infectious Diseases Business (2017-2022) 11.4.5 Trinity Biotech Recent Developments 11.5 Beckman Coulter/ Danaher 11.5.1 Beckman Coulter/ Danaher Company Details 11.5.2 Beckman Coulter/ Danaher Business Overview 11.5.3 Beckman Coulter/ Danaher POC Infectious Diseases Introduction 11.5.4 Beckman Coulter/ Danaher Revenue in POC Infectious Diseases Business (2017-2022) 11.5.5 Beckman Coulter/ Danaher Recent Developments 11.6 Becton Dickinson 11.6.1 Becton Dickinson Company Details 11.6.2 Becton Dickinson Business Overview 11.6.3 Becton Dickinson POC Infectious Diseases Introduction 11.6.4 Becton Dickinson Revenue in POC Infectious Diseases Business (2017-2022) 11.6.5 Becton Dickinson Recent Developments 11.7 Biomerieux 11.7.1 Biomerieux Company Details 11.7.2 Biomerieux Business Overview 11.7.3 Biomerieux POC Infectious Diseases Introduction 11.7.4 Biomerieux Revenue in POC Infectious Diseases Business (2017-2022) 11.7.5 Biomerieux Recent Developments 11.8 Bio-Rad 11.8.1 Bio-Rad Company Details 11.8.2 Bio-Rad Business Overview 11.8.3 Bio-Rad POC Infectious Diseases Introduction 11.8.4 Bio-Rad Revenue in POC Infectious Diseases Business (2017-2022) 11.8.5 Bio-Rad Recent Developments 11.9 Cepheid 11.9.1 Cepheid Company Details 11.9.2 Cepheid Business Overview 11.9.3 Cepheid POC Infectious Diseases Introduction 11.9.4 Cepheid Revenue in POC Infectious Diseases Business (2017-2022) 11.9.5 Cepheid Recent Developments 11.10 Diamedix 11.10.1 Diamedix Company Details 11.10.2 Diamedix Business Overview 11.10.3 Diamedix POC Infectious Diseases Introduction 11.10.4 Diamedix Revenue in POC Infectious Diseases Business (2017-2022) 11.10.5 Diamedix Recent Developments 11.11 Diasorin 11.11.1 Diasorin Company Details 11.11.2 Diasorin Business Overview 11.11.3 Diasorin POC Infectious Diseases Introduction 11.11.4 Diasorin Revenue in POC Infectious Diseases Business (2017-2022) 11.11.5 Diasorin Recent Developments 11.12 Eiken Chemical 11.12.1 Eiken Chemical Company Details 11.12.2 Eiken Chemical Business Overview 11.12.3 Eiken Chemical POC Infectious Diseases Introduction 11.12.4 Eiken Chemical Revenue in POC Infectious Diseases Business (2017-2022) 11.12.5 Eiken Chemical Recent Developments 11.13 Enzo Biochem 11.13.1 Enzo Biochem Company Details 11.13.2 Enzo Biochem Business Overview 11.13.3 Enzo Biochem POC Infectious Diseases Introduction 11.13.4 Enzo Biochem Revenue in POC Infectious Diseases Business (2017-2022) 11.13.5 Enzo Biochem Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
List of Tables Table 1. Global POC Infectious Diseases Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Flu Table 3. Key Players of Adenovirus Table 4. Key Players of Malaria Table 5. Key Players of Streptococcal Bacteremia Table 6. Key Players of Tuberculosis (TB) Table 7. Key Players of Occult Blood Table 8. Key Players of HIV Table 9. Global POC Infectious Diseases Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 10. Global POC Infectious Diseases Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 11. Global POC Infectious Diseases Market Size by Region (2017-2022) & (US$ Million) Table 12. Global POC Infectious Diseases Market Share by Region (2017-2022) Table 13. Global POC Infectious Diseases Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 14. Global POC Infectious Diseases Market Share by Region (2023-2028) Table 15. POC Infectious Diseases Market Trends Table 16. POC Infectious Diseases Market Drivers Table 17. POC Infectious Diseases Market Challenges Table 18. POC Infectious Diseases Market Restraints Table 19. Global POC Infectious Diseases Revenue by Players (2017-2022) & (US$ Million) Table 20. Global POC Infectious Diseases Revenue Share by Players (2017-2022) Table 21. Global Top POC Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POC Infectious Diseases as of 2021) Table 22. Ranking of Global Top POC Infectious Diseases Companies by Revenue (US$ Million) in 2021 Table 23. Global 5 Largest Players Market Share by POC Infectious Diseases Revenue (CR5 and HHI) & (2017-2022) Table 24. Key Players Headquarters and Area Served Table 25. Key Players POC Infectious Diseases Product Solution and Service Table 26. Date of Enter into POC Infectious Diseases Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global POC Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 29. Global POC Infectious Diseases Revenue Market Share by Type (2017-2022) Table 30. Global POC Infectious Diseases Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 31. Global POC Infectious Diseases Revenue Market Share by Type (2023-2028) Table 32. Global POC Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 33. Global POC Infectious Diseases Revenue Share by Application (2017-2022) Table 34. Global POC Infectious Diseases Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 35. Global POC Infectious Diseases Revenue Share by Application (2023-2028) Table 36. North America POC Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 37. North America POC Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 38. North America POC Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 39. North America POC Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 40. North America POC Infectious Diseases Market Size by Country (2017-2022) & (US$ Million) Table 41. North America POC Infectious Diseases Market Size by Country (2023-2028) & (US$ Million) Table 42. Europe POC Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 43. Europe POC Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 44. Europe POC Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 45. Europe POC Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 46. Europe POC Infectious Diseases Market Size by Country (2017-2022) & (US$ Million) Table 47. Europe POC Infectious Diseases Market Size by Country (2023-2028) & (US$ Million) Table 48. Asia Pacific POC Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 49. Asia Pacific POC Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 50. Asia Pacific POC Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 51. Asia Pacific POC Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 52. Asia Pacific POC Infectious Diseases Market Size by Region (2017-2022) & (US$ Million) Table 53. Asia Pacific POC Infectious Diseases Market Size by Region (2023-2028) & (US$ Million) Table 54. Latin America POC Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 55. Latin America POC Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 56. Latin America POC Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 57. Latin America POC Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 58. Latin America POC Infectious Diseases Market Size by Country (2017-2022) & (US$ Million) Table 59. Latin America POC Infectious Diseases Market Size by Country (2023-2028) & (US$ Million) Table 60. Middle East and Africa POC Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 61. Middle East and Africa POC Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 62. Middle East and Africa POC Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 63. Middle East and Africa POC Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 64. Middle East and Africa POC Infectious Diseases Market Size by Country (2017-2022) & (US$ Million) Table 65. Middle East and Africa POC Infectious Diseases Market Size by Country (2023-2028) & (US$ Million) Table 66. Abbott Company Details Table 67. Abbott Business Overview Table 68. Abbott POC Infectious Diseases Product Table 69. Abbott Revenue in POC Infectious Diseases Business (2017-2022) & (US$ Million) Table 70. Abbott Recent Developments Table 71. Meridian Bioscience Company Details Table 72. Meridian Bioscience Business Overview Table 73. Meridian Bioscience POC Infectious Diseases Product Table 74. Meridian Bioscience Revenue in POC Infectious Diseases Business (2017-2022) & (US$ Million) Table 75. Meridian Bioscience Recent Developments Table 76. Orasure Technologies Company Details Table 77. Orasure Technologies Business Overview Table 78. Orasure Technologies POC Infectious Diseases Product Table 79. Orasure Technologies Revenue in POC Infectious Diseases Business (2017-2022) & (US$ Million) Table 80. Orasure Technologies Recent Developments Table 81. Trinity Biotech Company Details Table 82. Trinity Biotech Business Overview Table 83. Trinity Biotech POC Infectious Diseases Product Table 84. Trinity Biotech Revenue in POC Infectious Diseases Business (2017-2022) & (US$ Million) Table 85. Trinity Biotech Recent Developments Table 86. Beckman Coulter/ Danaher Company Details Table 87. Beckman Coulter/ Danaher Business Overview Table 88. Beckman Coulter/ Danaher POC Infectious Diseases Product Table 89. Beckman Coulter/ Danaher Revenue in POC Infectious Diseases Business (2017-2022) & (US$ Million) Table 90. Beckman Coulter/ Danaher Recent Developments Table 91. Becton Dickinson Company Details Table 92. Becton Dickinson Business Overview Table 93. Becton Dickinson POC Infectious Diseases Product Table 94. Becton Dickinson Revenue in POC Infectious Diseases Business (2017-2022) & (US$ Million) Table 95. Becton Dickinson Recent Developments Table 96. Biomerieux Company Details Table 97. Biomerieux Business Overview Table 98. Biomerieux POC Infectious Diseases Product Table 99. Biomerieux Revenue in POC Infectious Diseases Business (2017-2022) & (US$ Million) Table 100. Biomerieux Recent Developments Table 101. Bio-Rad Company Details Table 102. Bio-Rad Business Overview Table 103. Bio-Rad POC Infectious Diseases Product Table 104. Bio-Rad Revenue in POC Infectious Diseases Business (2017-2022) & (US$ Million) Table 105. Bio-Rad Recent Developments Table 106. Cepheid Company Details Table 107. Cepheid Business Overview Table 108. Cepheid POC Infectious Diseases Product Table 109. Cepheid Revenue in POC Infectious Diseases Business (2017-2022) & (US$ Million) Table 110. Cepheid Recent Developments Table 111. Diamedix Company Details Table 112. Diamedix Business Overview Table 113. Diamedix POC Infectious Diseases Product Table 114. Diamedix Revenue in POC Infectious Diseases Business (2017-2022) & (US$ Million) Table 115. Diamedix Recent Developments Table 116. Diasorin Company Details Table 117. Diasorin Business Overview Table 118. Diasorin POC Infectious Diseases Product Table 119. Diasorin Revenue in POC Infectious Diseases Business (2017-2022) & (US$ Million) Table 120. Diasorin Recent Developments Table 121. Eiken Chemical Company Details Table 122. Eiken Chemical Business Overview Table 123. Eiken Chemical POC Infectious Diseases Product Table 124. Eiken Chemical Revenue in POC Infectious Diseases Business (2017-2022) & (US$ Million) Table 125. Eiken Chemical Recent Developments Table 126. Enzo Biochem Company Details Table 127. Enzo Biochem Business Overview Table 128. Enzo Biochem POC Infectious Diseases Product Table 129. Enzo Biochem Revenue in POC Infectious Diseases Business (2017-2022) & (US$ Million) Table 130. Enzo Biochem Recent Developments Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Global POC Infectious Diseases Market Share by Type: 2021 VS 2028 Figure 2. Flu Features Figure 3. Adenovirus Features Figure 4. Malaria Features Figure 5. Streptococcal Bacteremia Features Figure 6. Tuberculosis (TB) Features Figure 7. Occult Blood Features Figure 8. HIV Features Figure 9. Global POC Infectious Diseases Market Share by Application: 2021 VS 2028 Figure 10. Hospital& Clinics Case Studies Figure 11. Clinical Diagnostic Laboratories Case Studies Figure 12. Homecare Settings Case Studies Figure 13. POC Infectious Diseases Report Years Considered Figure 14. Global POC Infectious Diseases Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 15. Global POC Infectious Diseases Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global POC Infectious Diseases Market Share by Region: 2021 VS 2028 Figure 17. Global POC Infectious Diseases Market Share by Players in 2021 Figure 18. Global Top POC Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POC Infectious Diseases as of 2021) Figure 19. The Top 10 and 5 Players Market Share by POC Infectious Diseases Revenue in 2021 Figure 20. North America POC Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 21. North America POC Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 22. North America POC Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 23. North America POC Infectious Diseases Market Size Share by Country (2017-2028) Figure 24. United States POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Canada POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Europe POC Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 27. Europe POC Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 28. Europe POC Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 29. Europe POC Infectious Diseases Market Size Share by Country (2017-2028) Figure 30. Germany POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. France POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. U.K. POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Italy POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Russia POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Nordic Countries POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Asia-Pacific POC Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 37. Asia Pacific POC Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 38. Asia Pacific POC Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 39. Asia Pacific POC Infectious Diseases Market Size Share by Region (2017-2028) Figure 40. China POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Japan POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. South Korea POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Southeast Asia POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. India POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Australia POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 46. Latin America POC Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 47. Latin America POC Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 48. Latin America POC Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 49. Latin America POC Infectious Diseases Market Size Share by Country (2017-2028) Figure 50. Mexico POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Brazil POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. Middle East & Africa POC Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 53. Middle East and Africa POC Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 54. Middle East and Africa POC Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 55. Middle East and Africa POC Infectious Diseases Market Size Share by Country (2017-2028) Figure 56. Turkey POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. Saudi Arabia POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. UAE POC Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 59. Abbott Revenue Growth Rate in POC Infectious Diseases Business (2017-2022) Figure 60. Meridian Bioscience Revenue Growth Rate in POC Infectious Diseases Business (2017-2022) Figure 61. Orasure Technologies Revenue Growth Rate in POC Infectious Diseases Business (2017-2022) Figure 62. Trinity Biotech Revenue Growth Rate in POC Infectious Diseases Business (2017-2022) Figure 63. Beckman Coulter/ Danaher Revenue Growth Rate in POC Infectious Diseases Business (2017-2022) Figure 64. Becton Dickinson Revenue Growth Rate in POC Infectious Diseases Business (2017-2022) Figure 65. Biomerieux Revenue Growth Rate in POC Infectious Diseases Business (2017-2022) Figure 66. Bio-Rad Revenue Growth Rate in POC Infectious Diseases Business (2017-2022) Figure 67. Cepheid Revenue Growth Rate in POC Infectious Diseases Business (2017-2022) Figure 68. Diamedix Revenue Growth Rate in POC Infectious Diseases Business (2017-2022) Figure 69. Diasorin Revenue Growth Rate in POC Infectious Diseases Business (2017-2022) Figure 70. Eiken Chemical Revenue Growth Rate in POC Infectious Diseases Business (2017-2022) Figure 71. Enzo Biochem Revenue Growth Rate in POC Infectious Diseases Business (2017-2022) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed